|
12 Oct 2026 |
Indraprastha Medical
|
Consensus Share Price Target
|
331.20 |
550.00 |
- |
66.06 |
buy
|
|
|
|
|
03 Nov 2025
|
Indraprastha Medical
|
Anand Rathi
|
331.20
|
690.00
|
575.15
(-42.42%)
|
108.33 |
Buy
|
|
|
In-line with our estimate, Indraprastha Medical Corporation’s Q2 revenue/EBITDA/PAT rose 9/12/17% y/y. The EBITDA margin rose 50bps y/y to 18.7% (vs. ARe of 19.3%), on improved volume and prices.
|